| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_54844c99385d5e8915aa8069146ce5ce |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4402 |
| filingDate |
2009-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64771387803eab1a52836ad7556671d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18335dc6ef22810e7de88c3c90198642
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49a64b95ad6a82b5c16d9c584ac31dd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12e8d4775d7ed7bc12d1599be17db42f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0d1e680a3333313195420d65c89f18e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63dc6e299747df424c0c8aba7398a05b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b6403982e07eec296d753be2ff2d028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd444387c34bbef37bbd626f59e0290d |
| publicationDate |
2011-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2346828-A1 |
| titleOfInvention |
Piperazine derivatives used as cav2.2 calcium channel modulators |
| abstract |
The present invention relates to novel piperazine derivatives (I); to processes for their preparation; to pharmaceutical compositions containing the derivatives; and to the use of the derivatives in therapy to treat diseases for which blocking the Ca V 2.2 calcium channels is beneficial. |
| priorityDate |
2008-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |